Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
29.06
+0.11 (0.38%)
At close: Apr 15, 2025, 4:00 PM
27.51
-1.55 (-5.33%)
Pre-market: Apr 16, 2025, 4:11 AM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.72 billion as of April 15, 2025. Its market cap has decreased by -11.67% in one year.
Market Cap
1.72B
Enterprise Value
715.45M
1-Year Change
-11.67%
Ranking
Category
Stock Price
$29.06
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.72B, an increase of 179.86%. That is a compound annual growth rate of 30.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2025 | 1.71B | -44.57% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.40B |
| UnitedHealth Group | 536.99B |
| Johnson & Johnson | 371.98B |
| AbbVie | 316.82B |
| Novo Nordisk | 294.67B |
| Abbott Laboratories | 221.92B |
| AstraZeneca | 210.97B |
| Novartis AG | 206.74B |